Feb.
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
March 25, 2026 — Catalyst MedTech, a provider of nuclear medicine and molecular imaging solutions, has announced it is ...
Feb. 19, 2026 — Positrigo, a Swiss based company developing nuclear medical devices to advance functional brain imaging ...
Feb. 12, 2026 — Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...
Jan. 8, 2026 — RefleXion Medical, an external-beam theranostic oncology company, has announced the U.S. Food and Drug ...
Dec.16, 2025 — Three international nuclear medicine organizations — the SNMMI Clinical Trials Network (SNMMI-CTN), the ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
Nov. 18, 2025 — Siemens Healthineers positron emission tomography (PET) radiopharmaceutical companies PETNET Solutions ...
Oct. 22, 2025 — Vistim Labs has announced that its flagship product, Ceregram, is officially ready for launch in ...
Oct. 16, 2025 — A strategic collaboration between UC San Diego Health and GE HealthCare will focus on bringing advanced ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
Sept. 20, 2025 — A promising new PET tracer can visualize a protein that is commonly overexpressed in triple-negative ...
Sept. 11, 2025 — A new PET tracer can provide insights into how spinal cord injuries affect not only the spinal cord ...
July 22, 2025 — GE HealthCare has topped a U.S. Food and Drug Administration (FDA) list of AI-enabled medical device ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
Jun. 24, 2025 — GE HealthCare has announced that the U.S. Food and Drug Administration (FDA) approved an updated label ...
June 19, 2025 – dGenThera, Inc., a biotechnology company pioneering theranostic molecular pairs, and Nusano, a physics ...
May 30, 2025 — GE HealthCare recently announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) ...
Jan. 30, 2025 – Earlier this month, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimer’s ...
Jan. 24, 2025 —The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of Nuclear ...
Jan. 8, 2025 – The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimer’s Association have ...
Oct. 21, 2024 — Siemens Healthineers recently received Food and Drug Administration clearance for two new features in ...
Aug. 28, 2024 – AC Immune SA recently announced that its partner Life Molecular Imaging (LMI) has received Fast Track ...
April 06, 2026 